From bench to cageside: Risk assessment for rodent pathogen contamination of cells and biologics

ILAR Journal

Volumn 49, Issue 3, 2008, Pages 310-315

  Peterson, Norman C ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL LINE; FOOD CONTAMINATION; ISOLATION AND PURIFICATION; LACTIC DEHYDROGENASE TOGAVIRUS; METHODOLOGY; MOUSE; MYCOPLASMA; RAT; REVIEW; RISK ASSESSMENT; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; FOOD CONTAMINATION; LACTATE DEHYDROGENASE-ELEVATING VIRUS; MICE; MYCOPLASMA; RATS; RISK ASSESSMENT;

EID: 58149353025     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.49.3.310     Document Type: Review

References (49)

1. Agca Y, Bauer BA, Johnson DK, Critser JK, Riley LK. 2007. Detection of mouse parvovirus in mus musculus gametes, embryos, and ovarian tissues by polymerase chain reaction assay. Comp Med 57:51-56.
2. Al-Hello H, Davydova B, Smura T, Kaialainen S, Ylipaasto P, Saario E, Hovi T, Rieder E, Roivainen M. 2005. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo. J Med Virol 75:566-574.
3. Aoki T, Herberman RB, Hartley JW, Liu M, Walling MJ, Nunn M. 1977. Surface antigens on transplantable tumor cell lines producing mouse type C viruses. J Natl Cancer Inst 58:1069-1078.
4. Bauer BA, Besch-Williford CL, Riley LK. 2004. Comparison of the mouse antibody production (MAP) assay and polymerase chain reaction (PCR) assays for the detection of viral contaminants. Biologicals 32: 177-182.
5. Bazin R, Lemieux R. 1989. Increased proportion of B cell hybridomas secreting monoclonal antibodies of desired specificity in cultures containing macrophage-derived hybridoma growth factor (IL-6). J Immunol Methods 116:245-249.
6. Besselsen DG, Franklin CL, Livingston RS, Riley LK. 2008. Lurking in the shadows: Emerging rodent infectious diseases. ILAR J 49:277-290.
7. Bhatt PN, Jacoby RO, Barthold SW. 1986. Contamination of transplantable murine tumors with lymphocytic choriomeningitis virus. Lab Anim Sci 36:136-139.
8. Blank WA, Henderson KS, White LA. 2004. Virus PCR assay panels: An alternative to the mouse antibody production test. Lab Anim 33:26-32.
9. Bowen GS, Calisher CH, Winkler WG, Kraus AL, Fowler EH, Garman RH, Fraser DW, Hinman AR. 1975. Laboratory studies of a lymphocytic choriomeningitis virus outbreak in man and laboratory animals. Am J Epidemiol 102:233-240.
10. Chen Z, Plagemann PG. 1997. Detection of lactate dehydrogenaseelevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cell. J Virol Methods 65:227-236.
11. Dodds JW, Kelleher RJ, Menon M, Besch-Williford C. 2003. Mycoplasma arginini-associated septic arthritis and wasting in SCID mice (abstract). Contemp Top Lab Anim 42:66.
12. Dykewicz CA, Dato VM, Fisher-Hoch SP, Howarth MV, Perez-Oronoz GI, Ostroff SM, Gary H Jr, Schonberger LB, McCormick JB. 1992. Lymphocytic choriomeningitis outbreak associated with nude mice in a research institute. JAMA 267:1349-1353.
13. Garnick RL. 1996. Experience with viral contamination in cell culture. Dev Biol Stand 88:49-56.
14. Grimwood BG. 1985. Viral contamination of a subline of toxoplasma gondii RH. Infect Immun 50:917-918.
15. Harris WJ, Adair JR, eds. 1997. Antibody Therapeutics. Boca Raton: CRC Press. p 3-137.
16. Hirashima M, Kataoka H, Nishikawa S, Matsuyoshi N, Nishikawa S. 1999. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 93:1253-1263.
17. Ike F, Bourgade F, Ohsawa K, Sato H, Morikawa S, Saijo M, Kurane I, Takimoto K, Yamada YK, Jaubert J, Berard M, Nakata H, Hiraiwa N, Mekada L, Takakura A, Itoh T, Obata Y, Yoshiki A, Montagutelli X. 2007. Lymphocytic choriomeningitis infection undetected by dirtybedding sentinel monitoring and revealed after embryo transfer of an inbred strain derived from wild mice. Comp Med 57:272-281.
18. Jacoby RO, Lindsey JR. 1998. Risks of infection among laboratory rats and mice at major biomedical research institutions. ILAR J 39:266-271.
19. Kitamura N, Iwamura T, Taniguchi S, Yamanari H, Kawano MA, Hollingsworth K, Setoguchi T. 2000. High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice. Clin Exp Metastasis 18:561-571.
20. Kouro T, Yokota T, Welner R, Kincade PW. 2007. Isolation and differentiation of stem and progenitor cells. In: Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W, Brown P, Donovan JC, eds. Current Protocols in Immunology. Hoboken: John Wiley and Sons. p 22F1.1-22F1.9.
21. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87:811-822.
22. Kyuwa S. 1997. Replication of murine coronaviruses in mouse embryonic stem cell lines in vitro. Exp Anim 46:311-313.
23. Lamontagne L, Descoteaux JP, Jolicoeur P. 1989. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity. J Immunol 142:4458-4465.
24. Lazaro CA, Rhim JA, Yamada Y, Fausto N. 1998. Generation of hepatocytes from oval cell precursors in culture. Cancer Res 58:5514-5522.
25. Lindsey JR, Boorman GA, Collins MJ, Hsu CK, Van Hoosier GL, Wagner JE, eds. 1991. Infectious Diseases of Mice and Rats. Washington: National Academy Press.
26. Lipman NS, Perkins S, Nguyen H, Pfeffer M, Meyer H. 2000. Mousepox resulting from use of ectromelia virus-contaminated, imported mouse serum. Comp Med 50:426-435.
27. Mahabir E, Bauer B, Schmidt J. 2008. Rodent and germplasm trafficking: Risks of microbial contamination in a high-tech biomedical world. ILAR J 49:347-355.
28. Mase M, Tanimura N, Imada T, Okamatsu M, Tsukamoto K, Yamaguchi S. 2006. Recent H5N1 avian influenza A virus increases rapidly in virulence to mice after a single passage in mice. J Gen Virol 87(Pt 12):3655-3659.
29. Morton CL, Houghton PJ. 2007. Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2:247-250.
30. Nicklas W, Weiss J. 2000. Survey of embryonic stem cells for murine infective agents. Comp Med 50:410-411.
31. Nicklas W, Kraft V, Meyer B. 1993. Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab Anim Sci 43:296-300.
32. Nicklas W, Giese M, Zawatzky R, Kirchner H, Eaton P. 1988. Contamination of a monoclonal antibody with LDH-virus causes interferon induction. Lab Anim Sci 38:152-154.
33. Nakai N, Kawaguchi C, Nawa K, Kobayashi S, Katsuta Y, Watanabe M. 2000. Detection and elimination of contaminating microorganisms in transplantable tumors and cell lines. Exp Anim 49:309-313.
34. Okumura A, Machii K, Azuma S, Toyoda Y, Kyuwa S. 1996. Maintenance of pluripotency in mouse embryonic stem cells persistently infected with murine coronavirus. J Virol 70:4146-4149.
35. Orlik O, Altaner C. 1988. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells. J Immunol Methods 115:55-59.
36. Peters C, Paterson Y. 2003. Enhancing the immunogenicity of bioengineered listeria monocytogenes by passaging through live animal hosts. Vaccine 21:1187-1194.
37. Previsani N, Fontana S, Hirt B, Beard P. 1997. Growth of the parvovirus minute virus of mice MVMp3 in EL4 lymphocytes is restricted after cell entry and before viral DNA amplification: Cell-specific differences in virus uncoating in vitro. J Virol 71:7769-7780.
38. Roseto A, Guillemin MC, Chehimi J, Mazeron MC, Peries J. 1984. Elimination of mycoplasma, bacteria, and fungi contaminants of hybridoma cultures by intraperitoneal passage in the mouse. Hybridoma 3:297-300.
39. Schoondermark-van de Ven EM, Philipse-Bergmann IM, van der Logt JT. 2006. Prevalence of naturally occurring viral infections, Mycoplasma pulmonis and Clostridium piliforme in laboratory rodents in western Europe screened from 2000 to 2003. Lab Anim 40:137-143.
40. Shepherd AJ, Wilson NJ, Smith KT. 2003. Characterisation of endogenous retrovirus in rodent cell lines used for production of biologicals. Biologicals 31:251-260.
41. Sobel RE, Sadar MD. 2005. Cell lines used in prostate cancer research: A compendium of old and new lines-part 2. J Urol 173:360-372.
42. Suzuki T, Yanagihara K, Yoshida K, Seido T, Kuga N. 1977. Infectious murine type-C viruses released from human cancer cells transplated into nude mice. Gann (now Cancer Science) 68:99-106.
43. Takakura A, Ohnishi Y, Itoh T, Yoshimura M, Urano K, Ueyama Y. 2000. Decontamination of human xenotransplantable tumor with mouse hepatitis virus by implantation in nude rat: A case report. Exp Anim 49:39-41.
44. Taupin P. 2007. Stem cells engineering for cell-based therapy. J Neural Eng 4:R59-R63.
45. Uno K, Takema M, Hidaka S, Tanaka R, Konishi T, Kato T, Nakamura S, Muramatsu S. 1990. Induction of antitumor activity in macrophages by mycoplasmas in concert with interferon. Cancer Immunol Immunother 32:22-28.
46. Ushio S, Iwaki K, Taniai M, Ohta T, Fukuda S, Sugimura K, Kurimoto M. 1995. Metastasis-promoting activity of a novel molecule, ag 243-5, derived from mycoplasma, and the complete nucleotide sequence. Microbiol Immunol 39:393-400.
47. Victor R, Chauzy C, Girard N, Gioanni J, d'Anjou J, Stora De Novion H, Delpech B. 1999. Human breast-cancer metastasis formation in a nudemouse model: Studies of hyaluronidase, hyaluronan and hyaluronanbinding sites in metastatic cells. Int J Cancer 82:77-83.
48. Watson J. 2008. New building, old parasite: Mesostigmatid mites-An ever-present threat to barrier facilities. ILAR J 49:303-309.
49. Yokoyama WM, Christensen M, Dos Santos G, Miller D. 2006. Production of monoclonal antibodies. In: Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W, Brown P, Donovan JC, eds. Current Protocols in Immunology. Hancock NJ: John Wiley and Sons. p 2.5.1-2.5.25.